Please turn JavaScript on
clarkstreetvalue icon

clarkstreetvalue

Want to stay in touch with the latest updates from Clarkstreetvalue? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: Clark Street Value

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.36 / day

Message History

A reader asked for my a new model on Braemar Hotels & Resorts (BHR), a luxury hotel REIT that I've personally lost a lot of money on in the past year.  My original thesis rested on former external manager Ashford Inc selling BHR outright and collecting their termination payment, but some noisy activists scared away potential buyers who were afraid any acquisition wouldn't...


Read full story

BlackRock TCP Capital Corp (TCPC) (~$345MM market cap) is a BDC launched in 2012 that was externally managed by Tennenbaum Capital Partners ("TCP") until April 2018 when BlackRock (BLK) purchased TCP and rebranded the BDC.  In late 2023, TCPC announced a merger with fellow BlackRock managed BDC, BlackRock Capital Investment Corp (BCIC), that was intended to scale the platform...


Read full story

Seritage Growth Properties (SRG) (~$90MM market cap) is the former PropCo formed in a 2015 rights offering to hold a portfolio of Sears (SHLD) free-standing and mall adjacent locations.  The original idea was to renovate and lease the former Sears boxes as they became vacant, eventually turning into a diversified retail REIT.  That thesis never sit well with me because many o...


Read full story

Apologies for the long layoff, I suddenly found myself important at work and have had to reduce my time spent on investing/blogging.  No promises, but I hope to be more active again.  A quick return to blogging post:

Artiva Biotherapeutics (ARTV) (~$210MM market cap) was a development stage biotech focused on its lead asset, AlloNK, a treatment for autoimmune diseases. ...


Read full story